{{Rsnum
|rsid=543215
|Chromosome=11
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=PGR
|position=101103302
|Gene_s=PGR
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 68.1 | 28.3 | 3.5
| HCB | 3.6 | 33.6 | 62.8
| JPT | 6.2 | 26.5 | 67.3
| YRI | 26.5 | 53.1 | 20.4
| ASW | 22.8 | 50.9 | 26.3
| CHB | 3.6 | 33.6 | 62.8
| CHD | 4.6 | 37.0 | 58.3
| GIH | 26.7 | 54.5 | 18.8
| LWK | 38.2 | 43.6 | 18.2
| MEX | 32.8 | 53.4 | 13.8
| MKK | 32.1 | 46.2 | 21.8
| TSI | 68.6 | 27.5 | 3.9
| HapMapRevision=28
}}Part of a haplotype [[Gs286]], standalone effect for [[endometrial cancer]] is ambiguous.

{{PMID Auto GWAS
|PMID=20547493
|Trait=Endometrial cancer
|Title=Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.
|RiskAllele=G
|Pval=0.65
|OR=1.12
|ORtxt=[0.95-1.33]
|OA=1
}}

{{PMID|15632380}} Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}